Abstract |
Crimean-Congo hemorrhagic fever (CCHF), is a fatal viral infection transmitted to humans through a tick bite or exposure to blood or tissues of viremic hosts. The clinical presentation is characterized by sudden onset high fever, headache, myalgia, abdominal pain and nausea- vomiting followed by gastrointestinal, urinary, respiratory tract and brain hemorrhage. Laboratory findings include leucopenia, thrombocytopenia, elevated liver enzymes, prolonged prothrombin time and activated partial thromboplastin time. We report a case of CCHF who was treated with a combination of DFPP and ribavirin therapy. As a result of this multimodal treatment, patient's clinical symptoms and laboratory findings improved gradually.
|
Authors | Başak C Meço, Osman Memikoğlu, Osman Ilhan, Erol Ayyıldız, Ceren Gunt, Necmettin Unal, Mehmet Oral, Melek Tulunay |
Journal | Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
(Transfus Apher Sci)
Vol. 48
Issue 3
Pg. 331-4
(Jun 2013)
ISSN: 1473-0502 [Print] England |
PMID | 23619328
(Publication Type: Case Reports, Journal Article)
|
Copyright | Copyright © 2013. Published by Elsevier Ltd. |
Chemical References |
|
Topics |
- Adult
- Animals
- Fibrinogen
(biosynthesis)
- Filtration
- Hemorrhagic Fever Virus, Crimean-Congo
- Hemorrhagic Fever, Crimean
(therapy)
- Humans
- International Normalized Ratio
- Male
- Plasmapheresis
(methods)
- Ribavirin
(therapeutic use)
- Tick Bites
- Treatment Outcome
- Viral Load
|